Zonisamide for the treatment of "off" periods in Japanese patients with Parkinson's disease
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2013
Price : $35 *
At a glance
- Drugs Zonisamide (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 01 Aug 2013 New trial record
- 20 Jun 2013 Primary endpoint 'Duration-of-treatment-failure' has been met.
- 20 Jun 2013 Results presented at the 17th International Congress of Parkinson's Disease and Movement Disorders.